These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date 2005-002323-14 Samanburður á þremur meðferðum við áreynsluþvagleka. bad-data
Not reported 2005-005438-11 Lipid-lowering effects of ACTH 2007-10-10 due-trials
Ongoing 2005-005928-13 Prospective randomized double blind trial on the use of Scopoderm patch for control of post-operative nausea and vomitting in patients undergoing gynecologic laparoscopic procedures. not-yet-due
Not reported 2006-003799-36 Effects of alcohol on brain function and autonomic nerves 2007-10-10 due-trials
Not reported Terminated 2007-000627-17 Serum profiles of paracetamol and glutathione after high doses of paracetamol for 6 days 2012-09-09 due-trials
Listed as ongoing, but also has a completion date 2008-003235-20 NOPHO - ALL 2008 2016-04-03 bad-data
Not reported 2010-021842-23 A randomized clinical trial of the effects of Tea tree essential oil on adult leg cellulitis of class II in the Eron/Dall classification system for cellulitis: Pilot study. 2011-05-16 due-trials
Not reported 2012-005216-26 A study of the effect of monocaprin in dental adhesive/dental gel on Candida infection in the oral cavity 2014-06-30 due-trials
Not reported 2013-000975-33 Novel Assays for the Determination of Urinary 2,8-Dihydroxyadenine and Other Key Urinary Purine Metabolites - Rare Diseases Clinical Research Network 2015-05-31 due-trials
Ongoing 2013-002067-26 Difference between dosages needed of proton pump inhibitors for females and males not-yet-due
Not reported 2015-002230-41 Pharmacokinetics of Proton Pump Inhibitors in a random Icelandic Population. 2017-03-31 due-trials
Ongoing 2017-004785-10 Iceland Screens Treats or Prevents Multiple Myeloma (iStopMM): A nationwide phase 2 trial of patients with smoldering and active multiple myeloma (MM) not-yet-due